Table 3. Age- and sex-specific prevalence of glucose disorders in the northeast (SHIP-TREND) and south (KORA F4) of Germany*.
| Age (years) | i-IFG | i-IGT | IFG+IGT | Unknown diabetes | ||||
| SHIP-TREND | KORA F4 | SHIP-TREND | KORA F4 | SHIP-TREND | KORA F4 | SHIP-TREND | KORA F4 | |
| n = 526 | n = 458 | n = 109 | n = 173 | n = 214 | n = 185 | n = 140 | n = 110 | |
| Men | ||||||||
| 35–44 | 34.3 (28.0–41.0) | 16.5 (12.5–21.2) | 2.8 (1.0–5.9) | 1.7 (0.5–3.9) | 6.5 (3.6–10.6) | 2.0 (0.7–4.3) | 2.3 (0.8–5.3) | 1.0 (0.2–2.9) |
| 45–54 | 38.7 (32.6–45.1) | 24.6 (19.6–30.0) | 4.0 (2.0–7.3) | 5.7 (3.3–9.1) | 7.7 (4.7–11.7) | 5.0 (2.8–8.2) | 5.6 (3.1–9.3) | 1.8 (0.6–4.1) |
| 55–64 | 37.0 (30.7–43.5) | 29.1 (24.1–34.5) | 3.5 (1.5–6.7) | 4.9 (2.7–7.9) | 17.4 (12.7–22.9) | 10.4 (7.2–14.3) | 13.0 (8.9–18.1) | 7.4 (4.8–11.0) |
| 65–74 | 31.0 (23.9–38.8) | 28.7 (23.2–34.6) | 4.4 (1.8–8.9) | 7.0 (4.2–10.8) | 22.8 (16.5–30.1) | 16.7 (12.3–21.8) | 13.9 (8.9–20.3) | 7.8 (4.8–11.7) |
| 75–79 | 18.8 (8.9–32.6) | 22.6 (14.6–32.6) | 8.3 (2.3–20.0) | 16.1 (9.3–25.2) | 16.7 (7.5–30.2) | 14.0 (7.7–22.7) | 16.7 (7.5–30.2) | 12.9 (6.8–21.5) |
| 35–79 | 34.8 (31.7–38.0) | 24.5 (22.1–27.0) | 3.9 (2.7–5.4) | 5.6 (4.4–7.0) | 13.0 (10.9–15.4) | 8.7 (7.2–10.4) | 8.8 (7.0–10.8) | 5.1 (3.9–6.5) |
| women | ||||||||
| 35–44 | 8.7 (5.7–12.7) | 3.8 (2.0–6.4) | 8.1 (5.1–11.8) | 2.9 (1.4–5.3) | 3.3 (1.5–6.1) | 0.6 (0.1–2.1) | 0.0 (0.0–1.3) | 0.6 (0.1–2.1) |
| 45–54 | 18.1 (13.9–22.9) | 8.1 (5.4–11.5) | 6.6 (4.1–10.0) | 5.2 (3.1–8.1) | 6.3 (3.8–9.6) | 1.4 (0.5–3.3) | 3.9 (2.1–6.8) | 1.7 (0.6–3.7) |
| 55–64 | 28.7 (25.5–34.3) | 14.7 (11.0–19.1) | 6.6 (4.0–10.2) | 6.6 (4.1–9.9) | 10.1 (6.9–14.2) | 9.4 (6.4–13.2) | 8.4 (5.4–12.2) | 4.7 (2.7–7.6) |
| 65–74 | 26.5 (20.2–33.6) | 19.2 (14.8–24.3) | 5.5 (2.7–9.9) | 13.6 (9.9–18.2) | 17.1 (11.9–23.4) | 11.2 (7.8–15.4) | 11.6 (7.3–17.2) | 5.2 (3.0–8.5) |
| 75–79 | 12.2 (3.4–28.2) | 14.0 (7.4–23.1) | 9.1 (1.9–24.3) | 18.6 (11.0–28.4) | 27.3 (13.3–45.5) | 9.3 (4.1–17.5) | 12.1 (3.4–28.2) | 10.5 (4.9–18.9) |
| 35–79 | 19.7 (17.4–22.2) | 11.2 (9.6–13.0) | 6.8 (5.4–8.5) | 7.5 (6.2–9.1) | 9.0 (7.3–10.8) | 5.6 (4.4–6.9) | 5.6 (4.3–7.2) | 3.4 (2.5–4.5) |
*The sample was restricted to participants without known diabetes and to participants who were fasting for ≥8 hours. Data of 2,557 participants with normal glucose tolerance were included but not shown (SHIP: n = 991; KORA: n = 1,618). Results are crude prevalences(%) and 95% confidence intervals if not otherwise specified. Significant regional differences (p<0.05) are highlighted in bold. Abbreviations: SHIP-TREND: Study of Health in Pomerania (2008–2012); KORA F4: Cooperative Health Research in the Region of Augsburg (2006–2008); i-IFG: isolated impaired fasting glucose: 5.6–6.9 mmol/l (100–125 mg/dl, fasting); i-IGT: isolated impaired glucose tolerance: 7.8–11.0 mmol/l (140–199 mg/dl, 2 hour postload).